🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Xue Meng

Korea Pharma (South Korea)

ORCID: 0009-0004-1698-4558
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: A First-In-Human Dose-Escalation Phase I Study of Basroparib, a Tankyrase Inhibitor, in Patients with Advanced-Stage Solid Tumors.

1 citations

Heinz‐Josef Lenz, Al B. Benson, Xue Meng, Uk-Il Kim, Song Hyun Kim +3 more